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Abstract Cellular senescence involves a reduction in
adult stem cell self-renewal, and epigenetic regulation of
gene expression is one of the main underlying mechanisms.
Here, we observed that the cellular senescence of human
umbilical cord blood-derived multipotent stem cells
(hUCB-MSCs) caused by inhibition of histone deacetylase
(HDAC) activity leads to down-regulation of high mobility
group A2 (HMGA2) and, on the contrary, to up-regulation
of p16
INK4A, p21
CIP1/WAF1 and p27
KIP1. We found that let-
7a1, let-7d, let-7f1, miR-23a, miR-26a and miR-30a were
increased during replicative and HDAC inhibitor-mediated
senescence of hUCB-MSCs by microRNA microarray and
real-time quantitative PCR. Furthermore, the conﬁgura-
tions of chromatins beading on these miRNAs were prone
to transcriptional activation during HDAC inhibitor-medi-
ated senescence. We conﬁrmed that miR-23a, miR-26a and
miR-30a inhibit HMGA2 to accelerate the progress of
senescence. These ﬁndings suggest that HDACs may play
important roles in cellular senescence by regulating the
expression of miRNAs that target HMGA2 through histone
modiﬁcation.
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Introduction
The epigenetic regulation of gene expression, including
chromatin modiﬁcations and translational regulation by
microRNAs (miRNAs), is an important mechanism con-
trolling stem cell self-renewal and pluripotency [1].
Histone modiﬁcation by acetylation, deacetylation and
methylation controls the chromatin structure by balancing
euchromatin and heterochromatin, and regulating the
expression of speciﬁc genes [2]. In the embryonic stem
(ES) cell genome, bivalent modiﬁcations marking large
regions of trimethylated lysine 27 residues in histone H3
(H3K27me3) that harbor smaller regions of H3K4me3 may
maintain the balance of key developmental genes for later
activation during ES cell differentiation [3]. During ES cell
differentiation and mammalian development, the acetyla-
tion of histones H3 and H4 decreases, whereas histone
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stem cells (MSCs), treatment with histone deacetylase
(HDAC) inhibitors decreases the stemness of the cells,
including their multipotency and self-renewal ability [5].
In a previous report, we showed that HDAC activity is
important for MSC self-renewal via balancing of polycomb
genes (PcGs) and jumonji domain containing 3 (JMJD3)
expression, which controls cellular senescence via the
regulation of histone deacetylase by p16
INK4A [6].
As a group, miRNAs are *22-nucleotide, non-coding
RNAs that regulate gene expression through the degrada-
tion or inhibition of translation of target mRNAs. This
regulation of gene expression is related to cellular differ-
entiation and proliferation. In particular, the timing of
miRNA expression during embryogenesis is critical, and
miRNAs have important roles during each developmental
stage [7]. Although key roles for miRNAs in controlling
stemness have been discovered, the mechanisms regulating
miRNA expression are not yet well known. The possibility
of epigenetic activation of tumor suppressor miRNAs in
human cancer cells has been suggested [8]. More recently,
several lines of evidence regarding the epigenetic control
of miRNA clusters have been reported. Several DNA
regions encoding tumor suppressor miRNAs are inacti-
vated by aberrant hypermethylation in human breast cancer
cell lines [9]. Furthermore, after treatment of AGS gastric
cancer cells with 5-aza-20-deoxycytidine (5-Aza-dC), a
DNA methyltransferase (DNMT) inhibitor, the expression
of a speciﬁc miRNA cluster can be restored through DNA
demethylation [10].
Epigenetic modifying drugs that inhibit HDAC and
DNMT have been intensely studied with regard to their
anticancer activity. The biology of miRNAs, which epi-
genetically regulate cellular homeostasis, has also been
well-studied in the ﬁeld of cancer research. Gene expres-
sion studies have shown that hundreds of miRNAs are
deregulated in cancer cells, and functional studies have
revealed that miRNAs are involved in the processes that
drive tumorigenesis [11]. Among all miRNAs, the let-7
family was one of the ﬁrst groups known to be required for
the maintenance of stem cell self-renewal [12]. Progenitor
cells show reduced expression of let-7 compared to more
differentiated mammary epithelial cells. Moreover,
enforced let-7 expression induces a loss of self-renewing
stem cells from mixed cultures [13]. In neural stem cells
(NSCs) from young mice, the overexpression of let-7b
increases Ink4a/Arf expression levels and decreases self-
renewal through the inhibition of high mobility group a2
(Hmga2) expression [14]. Although the relationship
between let-7 and Hmga2 has previously been reported in
mouse NSCs, the mechanism by which let-7 expression is
regulated has not yet been established in non-embryonic
tissues, leaving room for the possibility of let-7 regulation
at the transcriptional level [15]. One report showed that 5%
of human miRNAs in T24 bladder cancer cells are up-
regulated more than three-fold by treatment with a DNA
demethylating agent and an HDAC inhibitor. In particular,
miR-127 is signiﬁcantly induced by decreased DNA
methylation levels and increased active histone marks
around the promoter region of the miR-127 gene. These
results show that some miRNAs are regulated by epige-
netic modulation of their promoter regions and can be
induced by inhibitors of DNA methylation and HDACs [8].
The reciprocal regulatory mechanisms between these
epigenetic regulatory factors, however, have not been well-
studied in cancer or stem cell biology.
To elucidate the reciprocal regulatory mechanisms
between two key epigenetic factors, HDACs and miRNAs,
we investigated how miRNAs that affect cellular senes-
cence by targeting HMGA2 are regulated by HDAC
activity.
Materials and methods
Isolation and culture of hMSCs
Human adipose tissue-derived MSCs (hAD-MSCs) [16]
and human umbilical cord blood-derived MSCs (hUCB-
MSCs) [6, 17] were isolated and cultured as previously
described. In brief, hAD-MSCs were established from
freshly excised mammary fat tissues obtained from 20- to
30-year-old women during reduction mammoplasty pro-
cedures. The hAD-MSCs were maintained in K-NAC
medium supplemented with 2 mM N-acetyl-L-cysteine
(Sigma-Aldrich, St. Louis, MO) and L-ascorbic acid
(0.2 mM, Sigma-Aldrich).
The hUCB-MSCs were obtained from umbilical cord
blood immediately after full-term deliveries with the
informed consent of the mothers. hUCB-MSCs were used
in this experiment, and the hUCB-MSCs were maintained
in DMEM (Invitrogen, Carlsbad, CA) containing 10%
FBS. All procedures for the preparation and utilization of
hAD-MSCs (IRB no. 0611/001-001) and hUCB-MSCs
(IRB no. 0603/001-002) for research purposes were
approved by the institutional review board of Seoul
National University.
Senescence-associated beta-galactosidase staining
Senescence-associated beta-galactosidase (SA b-gal)
staining was carried out as described by Narita et al. [18]
with some modiﬁcations. The MSCs were seeded on six-
well plates at a density of 1 9 10
5/well for late-passage
cells and 5 9 10
4/well for early passage cells. Cells were
incubated for 3 days until reaching the appropriate
326 S. Lee et al.conﬂuence. For siRNA or anti-miRNA treatment, cells
were seeded at a density of 2 9 10
4/ml, and siRNA or anti-
miRNA was used to treat the cells at 50–60% conﬂuence.
The cells were washed twice with PBS and ﬁxed with 0.5%
glutaraldehyde in PBS (pH 7.2) for 5 min at room tem-
perature. Cells were then washed with PBS containing
MgCl2 (pH 7.2, 1 mM MgCl2) and stained in X-gal solu-
tion overnight at 37C. The cells were washed twice with
PBS, and images were captured with a microscope (IX70,
Olympus, Japan).
Immunocytochemistry
Immunocytochemical analyses of HMGA2 were per-
formed. Cells cultured with or without 4 mM VPA
(valproic acid, Sigma-Aldrich, St. Louis, MO) or 2 mM
NB (sodium butyrate, Sigma-Aldrich) for 3, 5 or 7 days
were ﬁxed in 4% paraformaldehyde and permeabilized
with 0.2% Triton X-100 (Sigma-Aldrich). The cells were
then incubated with 10% normal goat serum (Zymed
Laboratories Inc., San Francisco, CA) and stained with
antibodies against HMGA2 (1:200, Abcam, UK), followed
by incubation for 1 h with an Alexa 488-labeled secondary
antibody (1:1,000; Molecular Probes, Eugene, OR). The
nuclei were stained with Hoechst 33258 (1 lg/ml; 10 min),
and images were captured with a confocal microscope
(Eclipse TE200, Nikon, Japan).
Western blot analysis
Western blot analyses of HDAC1, HDAC2, HMGA2 and
p16
INK4A were performed as described previously [19].
MSCs cultured with or without HDAC inhibitors for 1, 3, 5
or 7 days were lysed with 50 mM Tris-HCl buffer con-
taining 0.1% Triton X-100 freshly supplemented with a
protease/phosphatase inhibitor cocktail. Proteins were then
separated using 7.5–15% SDS-PAGE and transferred to
nitrocellulose membranes at 350 mA for 5 h. All antibod-
ies were used according to the manufacturer’s instructions,
and protein bands were detected using an enhanced
chemiluminescence detection kit (Amersham Pharmacia
Biotech, UK).
RT-PCR
Total cellular RNA was extracted from cells with TRIzol
reagent
TM
(Invitrogen, Carlsbad, CA), according to the
manufacturer’s instructions. cDNA was synthesized by
adding the puriﬁed RNA and oligo-dT primers to Accu-
power RT premix (Bioneer, Korea), according to the
manufacturer’s instructions. PCR was conducted using
Accupower PCR premix (Bioneer, Korea). The primer sets
sequences used for this study are supplied in Table S2. All
PCR products were analyzed by gel electrophoresis on
1.5% agarose gels with ethidium bromide staining, fol-
lowed by ﬂuorescence digitization using a Bio-Rad GelDoc
XR system (Bio-Rad, USA). Semi-quantitative RT-PCR
was conducted by quantifying the RT-PCR bands using
ImageJ image analysis software (National Institutes of
Health, USA). Each gene was normalized against b-actin
or RPL13A as a housekeeping gene control. At least three
independent analyses were carried out for each gene.
Real-time quantitative PCR
Real-timeqPCRwasperformedusingSYBR
Green(Applied
Biosystems, Foster City, CA), according to the manufac-
turer’s protocol. b-actin was used as an internal control. All
amplicons were analyzed using Prism 7000 sequence
detection system 2.1 software (Applied Biosystems).
siRNA, anti-miRNA and mature miRNA
transfection study
Transient transfection assays were performed using com-
mercially available speciﬁc siRNAs for inhibition of
HDAC1, HDAC2 and HMGA2 along with a non-targeting
siRNA (ON Target plus SMARTpool, Dharmacon, USA).
Inhibition or overexpression of miRNAs was achieved by
commercial antisense miRNAs or mature miRNAs of hsa-
miR-23a, hsa-miR-26a and hsa-miR-30a with an appro-
priate miRNA precursor-negative control (anti-miRNA
inhibitor and miRNA precursor-negative control no. 1,
Ambion, USA). The siRNA, anti-miRNA and mature
miRNA transfections were done according to the manu-
facturer’s instructions. In brief, cells were seeded at a
concentration of 2 9 10
4/well, and siRNA-containing
medium (without the addition of antibiotics) was added
when the cells reached 50–60% conﬂuence. Cells were
incubated with 50 nM or 100 nM siRNA or 50 nM anti-
miRNAs or 50 nM mature miRNAs for 48 or 96 h. To
investigate the long-term effects of inhibition, the cells
were subcultured for 48–72 h after siRNA, anti-miRNA or
mature miRNA transfection. Subcultured cells were stabi-
lized for 24 h and incubated with siRNA, anti-miRNA or
mature miRNA for 48–72 h at the same concentration.
After inhibition, RNA extraction and subsequent RT-qPCR
or SA b-gal staining was performed for genetic or char-
acteristic analyses, respectively.
Chromatin immunoprecipitation (ChIP) assays
ThehUCB-MSCswereseededin10-cmplatesatadensityof
0.8–1 9 10
5 per plate and cultured with or without 4 mM
VPA or 2 mM NB for 1 or 3 days. ChIP assays were per-
formed according to the manufacturer’s protocol (ChIP
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immunoprecipitated using antibodies, according to the
manufacturer’sinstructions.Real-timeqPCRwasperformed
at a ﬁnal template dilution of 1:50. The primer sequences
usedintheChIPassaysinthisstudyaresuppliedinTableS3.
MTT assay
The effects of hsa-miR-23a inhibition on MSC prolifera-
tion were measured using the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT, Sigma-Aldrich,
USA) assay as described previously [19]. In brief, cells
were plated on 24-well plates at a density of 2 9 10
4/ml
and cultured for 24 h until reaching 50–60% conﬂuence.
The cells were then treated with 50 nM miR-23a inhibitor
(anti-miR
TM
miRNA inhibitor, Ambion, USA) and a
microRNA inhibitor control for 2 days. At the end of the
incubation, 50 ll of MTT stock solution (5 mg/ml) was
added, and the plates were incubated for another 4 h at
37C. Formazan crystals were solubilized with DMSO, and
the absorbance was measured with an EL800 microplate
reader (BIO-TEK Instruments, USA).
MicroRNA microarray analysis
Younggroup(passage5forhUCB-andhAD-MSCs)andold
group (passage 19 for hUCB- and hAD-MSCs; hUCB- and
hAD-MSCs treated with 2 mM VPA for 7 days) cells were
prepared for miRNA microarray analysis. Total RNA was
extracted from the human stem cells using TRI REAGENT
(Molecular Research Center, USA), according to the man-
ufacturer’s instructions. Each total RNA sample (2 lg) was
labeled and ampliﬁed using a ULS aRNA labeling kit
(Kreatech diagnostics, The Netherlands). The Cy5-labeled
aRNAs were resuspended in 10 ll of hybridization solution
(GenoCheck, Korea). We used Agilent human miRNA
arrays containing probes and annotation information for all
human miRNAs fromthe Sanger miRBASE publicdatabase
(Release12.0,September2008),with20probereplicatesper
array. We also used the Agilent human whole genome array,
which contains probes and annotation information for all
human genes sourced from the Genome Reference Consor-
tium Human Build 34 (GRCh34). GeneSpring GX software
was used for data normalization, clustering, selection of
changed miRNAs and statistical analysis. Gene expression
levelswerecalculated,andrelativesignalintensitiesforeach
gene were generated.
Statistical analysis
All experiments were conducted at least in triplicate
(n = 3), and results are expressed as the mean ± SD.
Statistical analysis was conducted via analysis of variance
(ANOVA), followed by Duncan’s multiple range tests or
Student’s t-test. p\0.05 was considered to be signiﬁcant.
Results
Replicative senescence in hUCB-MSCs down-regulates
HDAC1, HDAC2 and HMGA2, and up-regulates
CDKN inhibitors
To induce replicative senescence, we repeatedly subcul-
tured hUCB-MSCs in vitro. According to the cumulative
population doubling level, human MSCs began to lose
their proliferation potential at around the tenth passage
(Figure S1). Based on the CPDL data and the morpho-
logical characteristics of MSCs, the senescence status of
the MSCs was divided into three grades: early (less than 10
passages), intermediate (10–15 passages) and late stage
(more than 16 passages). To conﬁrm the senescence of late-
stage MSCs, SA b-gal staining was performed. As shown
in Fig. 1a, increased activity of b-gal was observed at late
stages compared to early stages. In our previous report,
HDAC1 and HDAC2, which are representative HDACs in
eukaryotes, were decreased in late-stage hUCB-MSCs. It
has been reported that trichostatin A, an HDAC inhibitor,
represses HMGA2 gene transcription [20] and decreases
Fig. 1 Replicative senescence of hUCB-MSCs. a MSCs undergo
replicative senescence upon repeated (more than 15 passages)
subculturing in vitro as shown by SA b-gal staining. b–c The
expression of HDAC1, HDAC2 and HMGA2 was down-regulated,
whereas p16
INK4A was up-regulated during repeated subculture-
induced senescence of MSCs as shown by immunoblot analysis
(b) and real-time qPCR (c). The expression levels of p21
CIP1/WAF1
and p27
KIP1 were also up-regulated as shown by real-time qPCR (c).
* and ** represent statistical signiﬁcance at the levels of p\0.05
and p\0.005, respectively
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INK4A expression during the aging
process [14]. Based on these previous reports, we investi-
gated the expression levels of HDAC1, HDAC2, HMGA2
and p16
INK4A in hUCB-MSCs at both early and late stages.
Both protein (Fig. 1b) and mRNA (Fig. 1c) levels of
HDAC1, HDAC2 and HMGA2 were decreased, whereas
p16
INK4A levels were increased in late-stage senescence of
MSCs. The mRNA levels of p21
CIP1/WAF1 and p27
KIP1
were also increased at late stages (Fig. 1c). Oxidative stress
was induced to hUCB-MSC using 300 lM hydrogen per-
oxide to compare the effects of stress-induced premature
senescence on HMGA2 and cyclin-dependent kinase
inhibitors such as p16
INK4A and p21
CIP1/WAF1. Treatment of
300 lMH 2O2-mediated oxidative stress increased SA
b-gal activity (Figure S3A) and elevation of p21
CIP1/WAF1
and down-regulation of HMGA2 mRNA levels were
observed (Figure S3B, C and D). However, p16
INK4A levels
were decreased during oxidative stress-mediated premature
senescence, suggesting that not p16
INK4A but p21
CIP1/WAF1
might involve in this process differently from replicative
senescence (Figure S3B and C).
HDAC inhibitors down-regulate HMGA2
and induce senescence
To determine whether HDAC activity was necessary for
the regulation of HMGA2 during cellular senescence in
hUCB-MSCs, we used the HDAC inhibitors valproic acid
(VPA) and sodium butyrate (NB). Based on our previous
report showing that 4 mM VPA or 2 mM NB was sufﬁ-
cient to induce senescence, we treated hUCB-MSCs for
7 days with 4 mM or 8 mM VPA and 2 mM or 4 mM NB,
and investigated the expression levels of HMGA2 and
other related genes. After treatment with the HDAC
inhibitors, real-time qPCR revealed that the expression
level of HMGA2 was decreased, whereas p16
INK4A and
p21
CIP1/WAF1 levels were increased in a concentration-
dependent manner in both VPA- and NB-treated hUCB-
MSCs. The expression of p27
KIP1, however, was only
increased in cells treated with 8 mM VPA; the other
treatment groups did not show elevated expression levels
of p27
KIP1 (Fig. 2a). We also evaluated the time course of
the changes in gene expression following treatment with
HDAC inhibitors using real-time qPCR and immunoblot
analyses. Both mRNA and protein levels of HMGA2 were
signiﬁcantly increased after 3 days of treatment (Fig. 2b,
c). The levels of p16
INK4A and p21
CIP1/WAF1 were up-reg-
ulated after 1 and 3 days, respectively, of treatment with
the HDAC inhibitors. In contrast, the expression of p27
KIP1
was not increased signiﬁcantly over the entire period of
treatment (Fig. 2b). Given that the expression of HMGA2
was decreased after 3 days of treatment with the HDAC
inhibitors, we treated hUCB-MSCs with the HDAC
inhibitors for 3, 5 and 7 days and investigated the expres-
sion pattern of HMGA2 using immunocytochemistry. The
nuclear localization of HMGA2 was conﬁrmed, and the
expression of HMGA2 was decreased in a time-dependent
manner (Fig. 2d).
HDAC1 and HDAC2 regulate HMGA2 expression,
and HMGA2 inhibition induces cellular senescence
Given that HDAC inhibitors have broad-spectrum biolog-
ical activity that is not restricted to HDAC inhibition alone,
speciﬁc inhibition of HDAC1 and HDAC2 was performed
using small interfering RNA (siRNA) to complement the
results seen with the HDAC inhibitors. First, decreased
expression levels of HDAC1 and HDAC2 were conﬁrmed
following treatment with siHDAC1 and siHDAC2,
respectively, using real-time qPCR, suggesting proper tar-
geting of the siRNAs (Fig. 3a). In addition, both siHDAC1
and siHDAC2 decreased the expression level of HMGA2
(Fig. 3a). To conﬁrm whether the inhibition of HMGA2
indeed led to the senescence of hUCB-MSCs, speciﬁc
targeting of HMGA2 was carried out using siRNA. After
inhibition of HMGA2, a decrease in HMGA2 expression
levels was conﬁrmed using real-time qPCR (Fig. 3b).
Consistently with our previous report [21], the inhibition of
HMGA2 as well as HDAC1 and HDAC2 led to the
senescence of hUCB-MSCs as shown by SA b-gal staining,
in addition to signiﬁcantly increased expression of
p21
CIP1/WAF1 and p16
INK4A (Fig. 3b, c).
Expression of miRNAs targeting HMGA2
is up-regulated in senescent hUCB-MSCs
Based on the aforementioned results, the inhibition of
HDACs, speciﬁcally HDAC1 and HDAC2, appears to
decrease HMGA2 expression. Among several reported
mechanisms, the let-7 miRNA family includes factors
known to regulate HMGA2 expression by targeting the 30
UTR of HMGA2 mRNA [14, 22–24]. Keeping this in
mind, we hypothesized that miRNAs up-regulated during
the senescence process, including the let-7 family, might
participate in decreasing the expression of HMGA2. We
found that all isotypes of the let7 family were up-regulated
following treatment with the HDAC inhibitors (Figure S4).
To investigate miRNAs other than the let-7 family that are
regulated during senescence following treatment with
HDAC inhibitors, miRNA microarray analysis comparing
early stage cells with senescent cells was performed. We
found 37 miRNAs that were signiﬁcantly up-regulated
(p\0.05) in the senescent hUCB-MSCs compared to the
early stage group. Using web-based miRNA database
programs such as Miranda, Targetscan and Pictar, which
use databases of miRNAs to mine target mRNAs, miRNAs
Histone deacetylase regulate microRNAs via HMGA2 329targeting the HMGA2 mRNA were investigated (Table S1
and Fig. 4b). Among 381 miRNAs indicated to target the
HMGA2 mRNA, 25 were up-regulated in senescent hUCB-
MSCs compared to the early stage group (Fig. 4a, b).
Among the miRNAs indicated by at least two database
programs to target HMGA2 mRNA, let-7a1, let-7d and let-
7f1, which constitute a let-7 cluster, and miR-23a, miR-26a
and miR-30a were selected for further experiments, and
their expression levels were analyzed by real-time qPCR.
As shown in Fig. 4c, the miRNAs selected by these criteria
were up-regulated by HDAC inhibitor-mediated induction
of senescence. Nevertheless, there were differences in
the efﬁciency and speciﬁc inhibition of both HDAC1
and HDAC2 by their respective siRNAs, leading to the
up-regulation of these miRNAs and suggesting that HDAC
activity may act as a speciﬁc regulatory signal for certain
miRNAs such as let-7a1, let-7d, let-7f1, miR-23a, miR-26a
and miR-30a (Fig. 4d). To compare the effects of HDAC
inhibitors with oxidative stress on HMGA2-targeing
miRNAs expression, we assessed the expression level of let
7a and miR-23a. Unlike HDAC inhibitor, oxidative stress
down-regulated the expression of let-7a and miR-23a,
suggesting that the mechanisms by which HMGA2
decrease might be different in between these two causes of
cellular senescence in hUCB-MSCs (Figure S3E).
Precursor forms of miRNAs increase after inhibition
of HDACs
Regulation of miRNA expression can be achieved at the
transcriptional or post-transcriptional level. Although
miRNA regulation at the post-transcriptional level is
becoming increasingly understood [7, 25], the factors that
may affect the transcriptional regulation of miRNAs are
not well characterized. Based on the observation that
HMGA2-targeting miRNAs increase following HDAC
Fig. 2 HDAC inhibitors down-
regulate HMGA2 and induce
senescence. a The HDAC
inhibitors VPA and NB were
used to treat hUCB-MSCs at
two concentrations for 7 days.
Real-time qPCR analysis was
performed to investigate the
expression levels of HMGA2,
p16
INK4A, p21
CIP1/WAF1 and
p27
KIP1 based on the
concentration of the HDAC
inhibitors. b hUCB-MSCs were
treated with 4 mM VPA or
2 mM NB for 1, 3, 5 and 7 days.
Real-time qPCR analysis was
performed to investigate the
expression levels of HMGA2,
p16
INK4A, p21
CIP1/WAF1 and
p27
KIP1 in a time-dependent
manner. c–d After treatment
with 4 mM VPA or 2 mM NB
for the indicated time periods,
immunoblot assay for HMGA2
and p16
INK4A (c) and
immunocytochemistry for
HMGA2 (d) were performed to
investigate the protein
expression levels
330 S. Lee et al.inhibitor treatment as shown in Fig. 4c, d, we investigated
the expression levels of the precursor forms of let-7a1,
let-7d, let-7f1, miR-23a, miR-26a and miR-30a using
RT-PCR analysis to determine whether the up-regulation
of miRNA expression occurred at the transcriptional level.
The precursor forms of these miRNAs were signiﬁcantly
up-regulated following treatment with the inhibitors
for HDAC 1 and/or 3 days Based on these results, we
hypothesized that miRNA expression might be regulated at
the transcriptional level following treatment with HDAC
inhibitors (Fig. 4e, f). Given that miRNA biogenesis begins
with transcription by RNA polymerase II, followed by
processing by RNase III, Drosha and Dicer, we investi-
gated the expression levels of these factors during HDAC
inhibitor-mediated cellular senescence in hUCB-MSCs.
The expression levels of Drosha and Dicer were unchanged
or slightly decreased during hUCB-MSC senescence
induced by treatment with HDAC inhibitors, suggesting
that the expression of let-7a1, let-7d, let-7f1, miR-23a,
miR-26a and miR-30a, which target HMGA2, might rather
be transcriptionally up-regulated than be enhanced by post-
transcriptional miRNA processing. In contrast, the regula-
tion of Lin28, which is reported to down-regulate let-7 at
the post-transcriptional level, inconsistently ﬂuctuated
following treatment with HDAC inhibitors, suggesting that
Lin28 may not be involved in the up-regulation of let-7
during HDAC inhibitor-induced senescence in hUCB-
MSCs (Figure S5).
HDAC inhibitors regulate epigenetic histone marks
in the miRNA genome
Based on the aforementioned results, factors that are well-
established as regulators of miRNA biogenesis at the
post-transcriptional level appear unlikely to be related to
the up-regulation of let-7a1, let-7d, let-7f1, miR-23a,
miR-26a and miR-30a during HDAC inhibitor-mediated
senescence. In contrast, considering the up-regulation of
individual miRNA precursor forms, miRNA biogenesis
might be modulated at the transcriptional level during the
progress of cellular senescence following the inhibition of
HDAC activity. To determine whether the transcription of
miRNAs was affected by HDAC activity, we investigated
the histone modiﬁcations in the chromatin at the site of
each miRNA coding region using chromatin immuno-
precipitation (ChIP) analysis. We found that acetylation
of histone H3 and H4 and trimethylation of histone H3 at
the lysine 4 residue (H3K4), all of which activate tran-
scription, were increased in the proximity of the coding
regions of let-7a1, let-7d, let-7f1, miR-23a, miR-26a and
miR-30a (Fig. 5b, c). Furthermore, histone H3K9Me3 and
H3K27Me3, which are known to repress transcription,
were decreased in the vicinity of these miRNAs. The
histone modiﬁcation patterns in miRNA coding regions in
the VPA-treated group were similar to those in the
NB-treated group (Fig. 5b, c). Given that the majority of
miRNAs are transcribed from genomic DNA by RNA
polymerase II, we investigated the level of enrichment of
RNA polymerase II at each miRNA coding region with
ChIP to support the hypothesis of miRNA transcriptional
activation via histone modiﬁcations. ChIP analysis and
subsequent real-time qPCR analysis showed an increase
in RNA polymerase II bound to DNA sequences in the
vicinity of the miRNA coding regions (Fig. 5d). To
conﬁrm whether the transcriptional regulation of these
miRNAs by the inhibition of HDACs is speciﬁc to
unprocessed primary forms of these miRNAs which target
HMGA2, we looked into other mRNA (OCT4) and
miRNA (miR-329) than HMGA2-targeting miRNAs.
First, we conﬁrmed that the expression levels of OCT4, a
well-known marker for undifferentiated embryonic stem
cells and pluripotency and miR-329, one of the highly
expressed miRNAs in mouse pluripotent stem cells, which
is conserved in human [26]. We found that OCT4 and
miR-329 expression levels were decreased after treatment of
4 mM VPA or 2 mM NB for more than 1 day (Figure S6A).
ChIP analysis showed that binding of histone H3K27me3
Fig. 3 HDAC1 and HDAC2 regulate HMGA2 expression, and
HMGA2 inhibition induces cellular senescence. a Speciﬁc inhibition
of HDAC1 and HDAC2 using siRNA was performed as described in
‘‘Materials and methods’’. The expression levels of HDAC1 and
HDAC2 were decreased as shown by RT-PCR analysis. Graphs
represent the semi-quantiﬁcation of RT-PCR results from at least
three independent experiments. b Speciﬁc inhibition of HDAC1 and
HDAC2 decreased the expression of HMGA2. c Speciﬁc down-
regulation of HDAC1, HDAC2 and HMGA2 was sufﬁcient to cause
cellular senescence in MSCs as shown by SA b-gal staining. The
expression levels of HMGA2 and p16
INK4A, p21
CIP1/WAF1 and
p27
KIP1 were determined by real-time qPCR analysis
Histone deacetylase regulate microRNAs via HMGA2 331increased at the OCT4 promoter region after treatment
of HDAC inhibitors (Figure S6B-C). Interestingly, the
genomic region encoding miR-329 showed prominently
increased enrichment of H3K9me3 and H3K27me3 but
decreased binding of H3K4me3 after treatment of HDAC
inhibitors in hUCB-MSCs (Figure S6B-C). Both the
OCT4 promoter and miR-329 coding region showed
decreased binding of RNA polymerase II; on the contrary,
the enrichment of EZH2, a methyltransferase of histone
H3K27, was increased after treatment of HDAC inhibi-
tors. In addition, increased enrichment of MeCP2 at the
promoter region of OCT4 suggested that DNA methyla-
tion may contribute to repression of OCT4 transcription
by treatment of HDAC inhibitor (Figure S6D). Taken
together, these data suggest that HDAC activity may
regulate transcription of HMGA2-targeting miRNAs by
modifying histone patterns bound to their genomic
contexts.
miR-23a, miR-26a and miR-30a regulate HMGA2
expression and senescence of hUCB-MSCs
It is well-known that the let-7 miRNA targets the HMGA2
mRNA. There have been no reports, however, about
whether miR-23a, miR-26a and miR-30a virtually target
the HMGA2 mRNA in the context of cellular senescence
or otherwise. Therefore, we investigated whether miR-23a,
miR-26a and miR-30a target HMGA2 mRNA by using a
speciﬁc miRNA inhibitors and mature miRNAs. Following
miRNA inhibitor-mediated inhibition of miR-23a, miR-26a
and miR-30a expression, we observed down-regulation of
the miRNAs and subsequent up-regulation of HMGA2
mRNA expression by real-time qPCR. On the contrary,
overexpression of the miRNAs induced down-regulation of
HMGA2 mRNA expression, suggesting that the miRNAs
might target HMGA2 (Fig. 6a, b). To investigate the
effects of the miRNAs on the expression levels of further
Fig. 4 Precursor and mature
miRNAs that target HMGA2
are up-regulated in HDAC
inhibitor-mediated senescence
of hUCB-MSCs. a The miRNAs
targeting HMGA2 were
searched using a screening
program for the miRNA
database. b HMGA2-targeting
miRNAs among those that were
up-regulated in the senescence
group in the microarray analysis
are represented by a Venn
diagram. c After treatment of
hUCB-MSCs with 4 mM VPA
or 2 mM NB for 3 days, the
expression of individual
microRNAs was analyzed using
real-time qPCR. d Following
speciﬁc inhibition of HDAC1
and HDAC2 using siRNAs, the
expression of individual
microRNAs was analyzed using
real-time qPCR. e After
treatment of hUCB-MSCs with
HDAC inhibitors at the
indicated concentrations and
durations, the expression levels
of precursor forms of miRNAs
were analyzed by RT-PCR.
f Semi-quantiﬁcation of the
PCR products was performed by
ImageJ analysis. The graph
shows the relative gene
expression of cells treated with
the HDAC inhibitors compared
with control cells. * and **
represent statistical signiﬁcance
at the levels of p\0.05 and
p\0.01, respectively
332 S. Lee et al.downstream factors of senescence such as p16
INK4A and
p21
CIP1/WAF1, real-time qPCR was performed after tran-
sient inhibition or over-expression of miRNAs using anti-
or mature miRNA oligonucleotides. Expression levels of
miR-23a and miR-30a were interrelated with p16
INK4A and
p21
CIP1/WAF1 expression levels (Fig. 6c, d). Anti-miRNA-
mediated inhibition of miR-23a and miR-30a decreased
expression of p16
INK4A and p21
CIP1/WAF1. On the other
hand, mature-miR-23a and miR-30a increased the expres-
sion level of the p16
INK4A and p21
CIP1/WAF1 (Fig. 6c, d).
Over-expression of miR-26a also increased p16
INK4A;
however, inhibition of miR-26a did not decrease the
expression of p16
INK4A. Regulation of p21
CIP1/WAF1
expression by miR-26a was not consistent with that regu-
lated by miR-23a and miR-30a (Fig. 6c, d). Inhibition or
over-expression of miR-23a and 30a affected cellular
senescence as evidenced by SA b-gal staining (Fig. 6e).
Anti-miR-23a and anti-miR-30a prevented cells from an
increase of b-galactosidase activity. Mature-miRNAs of
them enhanced staining status of SA b-gal. After regulation
of miR-26a, however, SA b-gal staining status did not
show prominent changes suggesting that the role miR-26a
may not be speciﬁc to HMGA2 (Fig. 6e). Taken together,
Fig. 5 miRNA expression is regulated by histone modiﬁcation.
a–d After treatment with HDAC inhibitors at the indicated concen-
trations for 1 day, a ChIP assay and real-time qPCR analysis were
performed. The binding of ﬁve types of acetylated or methylated
histone forms (b–c) and RNA polymerase II (d) was analyzed at the
DNA sites encoding the indicated miRNAs (a). The graph shows the
relative enrichment of target protein at the miRNA coding sites of
cells treated with the HDAC inhibitors compared with control cells.
* and ** represent statistical signiﬁcance at the levels of p\0.05
and p\0.01, respectively
Fig. 6 miR-23a, miR-26a and miR-30a miRNA inhibition or over-
expression regulate HMGA2 expression and senescence. Anti-
miRNAs or mature miRNAs were transfected as described in
Materials and Methods. a–b Following inhibition or overexpression
of miR-23a, miR-26a and miR-30a using anti- or mature-miRNA,
real-time qPCR was performed to evaluate the expression levels of
each miRNA (a) and HMGA2 (b). c–d After modulation of miR-23a,
miR-26a and miR-30a expression, the expression levels of p16
INK4A
(c) and p21
CIP1/WAF1(d) were investigated by real-time PCR. e After
inhibition or overexpression of miR-23a, miR-26a and miR-30a,
cellular senescence was investigated by SA b-gal staining
Histone deacetylase regulate microRNAs via HMGA2 333these results conﬁrm that miR-23a, miR-26a and miR-30a
regulate HMGA2 expression in cellular senescence.
Discussion
In this study, we identiﬁed an HDAC-HMGA2-p16
INK4A
regulatory pathway during the senescence process of
hUCB-MSCs. We used this pathway as a model of regu-
lation by miRNA expression. Furthermore, we conﬁrmed
that HDAC regulates miRNAs targeting the HMGA2
mRNA via histone modiﬁcations during the senescence
process induced by HDAC inhibitors.
HMGA proteins are abundant in pluripotent ES cells
and most malignant human tumors, but are not detectable
in normal somatic cells. They act as activators and
repressors of gene expression and most likely facilitate
DNA structural changes during the formation of special-
ized nucleoprotein structures at selected promoter regions
[27, 28]. HMGA2 is closely related to the maintenance of
self-renewal and pluripotency in stem cells, and the role of
HMGA2 in the self-renewal of mouse NSCs has been
reported [14]. In mouse NSCs, HMGA2 contributes to the
maintenance of self-renewal by reducing the expression of
p16
INK4A and p19
ARF; furthermore, the regulation of
HMGA2 by let-7b has also been suggested [14]. In the
present study, we used hUCB-MSCs to conﬁrm the down-
regulation of HMGA2 and the up-regulation of p16
INK4A
in both replicative and HDAC inhibitor-mediated senes-
cence (Fig. 1, 2 and Figure S2). We were able to reproduce
the results of Nishino et al. by showing that speciﬁc
inhibition of HMGA2 induced the cellular senescence of
hUCB-MSCs, followed by increased p16
INK4A and
p21
CIP1/WAF1 expression (Fig. 3). In a previous report,
Nishino [14] showed that Hmga2 is related to the control
of stem cell aging, and the regulation of p16
INK4A and
p19
ARF expression was revealed as a potential mechanisms
for induction of cellular scenescence. For both our data and
previously published results, however, the way in which
Hmga2 represses the Ink4a/Arf locus has not been estab-
lished. It should be determined whether HMGA2
cooperates with established repressors of the locus such as
polycomb group proteins, and the HMGA2-driven epige-
netic events that silence the locus should be identiﬁed [24].
Thus far, two key regulatory mechanisms of HMGA2
expression have been reported. One involves the let-7
family of miRNAs, which target the HMGA2 mRNA. The
30-UTR of human HMGA2 contains seven putative let-7
complementary sites [29]. The inhibitory effect of the let-7
family on HMGA2 has been conﬁrmed in various cancer
cell lines and mouse NSCs [14, 22, 23, 29]. The other
mechanism involves the transcriptional regulation of
HMGA2 via Sp1 and Sp3 during HDAC inhibitor
treatment [20]. Considering that some miRNAs play
important roles in maintaining the self-renewal and pluri-
potency of stem cells, we focused on the relationship
between miRNAs and HMGA2 during the senescence
process. Using miRNA microarray and database analyses,
we identiﬁed a number of hypothetical HMGA2-targeting
miRNAs that were up-regulated during cellular senescence
in hUCB-MSCs (Table S1, Fig. 4, 5, 6). Among these
miRNAs, we conﬁrmed that miR-23a, miR-26a and
miR-30a virtually regulate HMGA2 expression (Fig. 6). In
a previous report, Gao et al. [30] suggested that mito-
chondrial glutaminase is one of the targets of miR-23a;
however, other functions of miR-23a have not yet been
unveiled. Therefore, our novel ﬁnding that miR-23a targets
HMGA2 in the context of the cellular senescence of
hUCB-MSCs is important for uncovering the biological
functions of miR-23a.
To be functional, miRNAs must mature via a unique
biogenesis machinery. Drosha, DGCR8 and Dicer are the
primary factors that execute the biogenesis of miRNAs,
and their expression levels and functional changes can
affect the maturation process of miRNAs. Chiosea et al.
[31, 32] reported that the expression of Dicer, one of the
key miRNA processing enzymes, is up-regulated in pros-
tate cancer cells, suggesting a mechanism by which global
miRNA over-expression may occur in various cancer cell
lines. In that context, we found that the expression of
Drosha and Dicer was decreased slightly, unlike the
speciﬁc augmentation observed for the group of HMGA2-
targeting miRNAs, including let-7a1, let-7d, let-7f1,
miR-23a, miR-26a and miR-30a. These results suggest that
there are mechanisms of miRNA expression regulation
different from those involving the maturation enzymes. In
contrast, the ﬁnding of reduced levels of miRNA process-
ing enzymes during hUCB-MSC senescence may explain
how other groups of miRNAs are down-regulated.
Recent evidence suggests that the processing of several
primary miRNA transcripts (pri-miRNAs) is blocked post-
transcriptionally in embryonic stem cells, embryonal
carcinoma cells and primary tumors. Viswanathan et al.
showed that Lin28, a developmentally regulated RNA
binding protein, selectively blocks the processing of pri-let-
7 miRNAs in embryonic cells. They identiﬁed Lin28 as a
negative regulator of miRNA biogenesis and suggested
that Lin28 may play a central role in blocking miRNA-
mediated differentiation in stem cells and in certain cancers
[33]. In addition, Heo et al. [7] observed that Lin28
proteins act mainly in the cytoplasm by inducing the
uridylation of precursor let-7 (pre-let-7) at its 30 end. We
also evaluated the expression of LIN28 during cellular
senescence to conﬁrm whether it affected the expression
of let-7 family members. We found no consistent changes
in LIN28 expression, indicating that LIN28 does not
334 S. Lee et al.participate in the regulation of let-7 family members during
the cellular senescence of hUCB-MSCs (Figure S5).
Several lines of evidence support the epigenetic regu-
lation of miRNA transcription [8]. Lehmann et al. [9]
reported that hypermethylation of the miRNA genome is
strongly correlated with the methylation of known tumor
suppressor genes, and that treatment of various breast
cancer cell lines with a DNA demethylating agent, 5-aza-
20-deoxycytidine, reduces gene methylation of miRNA-9-1
and concomitantly reactivates its expression. In addition,
another report found that expression of a large miRNA
cluster (C19MC) was activated in human cancer cells
through the demethylation of a CpG-rich region [10].
Although epigenetic regulation of miRNA transcription has
been reported, the focus has been limited to DNA meth-
ylation of CpG-rich regions. There is a report suggesting
that histone acetylation plays an important role in chro-
matin remodeling and is required for gene activation [34].
Although several studies have suggested this possibility,
there has been no direct evidence showing the regulation of
miRNAs by histone modiﬁcations in a mammalian system
[35, 36]. Here, we found that HDAC regulates the tran-
scription of a group of miRNAs through the modiﬁcation
of histones. These results offer direct evidence that acti-
vating and repressive epigenetic marks on histones regulate
miRNA transcription, extending our understanding of the
cross-talk between systems of epigenetic control. It still
needs to be determined whether the inhibition of HDAC,
DNA methylation and miRNAs cross-regulate one another,
especially given the reports that HDAC inhibitors affect the
activity of DNMT [37, 38].
Transcription of the miRNA genome is mainly driven by
RNA polymerase II and is believed to share the charac-
teristics and regulatory mechanisms of class II genes. Class
II genes usually have three promoter regions: (1) a roughly
100-bp long core promoter domain, (2) the area immedi-
ately upstream of this region and (3) distal domains that are
thousands of base pairs (bps) in length [39, 40]. Typically,
RNA polymerase II binds to speciﬁc sequence elements
within the core promoter [40]. Using ChIP analysis with
random primers, we found that RNA polymerase II binds to
genomic coordinates ranging from -500 bp to ?500 bp of
the coding regions of miRNAs such as let-7a1, let-7d,
let-7f1, miR-23a, miR-26a and miR-30a. These regions
may include promoter regions or the miRNA coding region
itself if these transcriptional units exist for miRNA regu-
lation. The increase in RNA polymerase II binding to these
regions directly supports the transcriptional activation of
miRNAs such as let-7a1, let-7d, let-7f1, miR-23a, miR-26a
and miR-30a during the process of senescence. This ﬁnd-
ing, along with the active histone marks in the vicinity of
miRNA coding regions, may represent a mechanism by
which the transcription of miRNAs is increased.
Taken together, our novel ﬁndings show that HDACs
may play key roles in the regulation of certain miRNAs,
including let-7a1, let-7d, let-7f1, miR-23a, miR-26a and
miR-30a, in the context of the cellular senescence of
hUCB-MSCs. These miRNAs target HMGA2 mRNA,
which in turn regulates cellular senescence, including
p16
INK4A (Fig. 7). Given the previously reported interac-
tion between DNA methylation and miRNAs, these results
suggest cross-talk between epigenetic regulatory mecha-
nisms, including histone modiﬁcation, DNA methylation
and miRNAs. Further studies are necessary to elucidate the
detailed mechanisms underlying these processes.
Acknowledgment This work was supported by the National
Research Foundation of Korea (NRF) grant funded by the Korea
government (MEST, 2010-0020265).
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Boheler KR (2009) Stem cell pluripotency: a cellular trait that
depends on transcription factors, chromatin state and a check-
point deﬁcient cell cycle. J Cell Physiol 221:10–17
2. Shukla V, Vaissiere T, Herceg Z (2008) Histone acetylation and
chromatin signature in stem cell identity and cancer. Mutat Res
637:1–15
3. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar
RM, Chevalier B, Johnstone SE, Cole MF, Isono K, Koseki H,
Fuchikami T, Abe K, Murray HL, Zucker JP, Yuan B, Bell GW,
Herbolsheimer E, Hannett NM, Sun K, Odom DT, Otte AP,
Volkert TL, Bartel DP, Melton DA, Gifford DK, Jaenisch R,
Young RA (2006) Control of developmental regulators by poly-
comb in human embryonic stem cells. Cell 125:301–313
Fig. 7 Schematic diagram describing how transcriptional regulation
of miRNAs, which target mRNA of HMGA2, occurs in HDAC
inhibitor-mediated senescent MSCs. Alteration of histone codes in the
proximity of miRNAs by treatment of HDAC inhibitor in hUCB-
MSCs may lead the miRNAs to be prone to transcriptional activation.
Increase of HMGA2 targeting miRNAs represses HMGA2 expression
levels and causes p16
INK4A and p21
CIP1/WAF1, which eventually cause
cellular senescence and diminution of self-renewal in hUCB-MSCs
Histone deacetylase regulate microRNAs via HMGA2 3354. Meshorer E, Misteli T (2006) Chromatin in pluripotent embry-
onic stem cells and differentiation. Nat Rev Mol Cell Biol
7:540–546
5. Lee S, Park JR, Seo MS, Roh KH, Park SB, Hwang JW, Sun B,
Seo K, Lee YS, Kang SK, Jung JW, Kang KS (2009) Histone
deacetylase inhibitors decrease proliferation potential and multi-
lineage differentiation capability of human mesenchymal stem
cells. Cell Prolif 42:711–720
6. Jung JW, Lee S, Seo MS, Park SB, Kurtz A, Kang SK, Kang KS
(2010) Histone deacetylase controls adult stem cell aging by
balancing the expression of polycomb genes and jumonji domain
containing 3. Cell Mol Life Sci 67:1165–1176
7. Heo I, Joo C, Cho J, Ha M, Han J, Kim VN (2008) Lin28
mediates the terminal uridylation of let-7 precursor MicroRNA.
Mol Cell 32:276–284
8. Saito Y, Jones PA (2006) Epigenetic activation of tumor sup-
pressor microRNAs in human cancer cells. Cell Cycle
5:2220–2222
9. Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann
D, Langer F, Kreipe H (2008) Epigenetic inactivation of micr-
oRNA gene hsa-mir-9-1 in human breast cancer. J Pathol
214:17–24
10. Tsai KW, Kao HW, Chen HC, Chen SJ, Lin WC (2009) Epige-
netic control of the expression of a primate-speciﬁc microRNA
cluster in human cancer cells. Epigenetics 4:587–592
11. Negrini M, Nicoloso MS, Calin GA (2009) MicroRNAs and
cancer–new paradigms in molecular oncology. Curr Opin Cell
Biol 21:470–479
12. Bussing I, Slack FJ, Grosshans H (2008) let-7 microRNAs in
development, stem cells and cancer. Trends Mol Med
14:400–409
13. Ibarra I, Erlich Y, Muthuswamy SK, Sachidanandam R, Hannon
GJ (2007) A role for microRNAs in maintenance of mouse
mammary epithelial progenitor cells. Genes Dev 21:3238–3243
14. Nishino J, Kim I, Chada K, Morrison SJ (2008) Hmga2 promotes
neural stem cell self-renewal in young but not old mice by
reducing p16Ink4a and p19Arf expression. Cell 135:227–239
15. Hammond SM, Sharpless NE (2008) HMGA2, microRNAs, and
stem cell aging. Cell 135:1013–1016
16. Park JR, Jung JW, Lee YS, Kang KS (2008) The roles of Wnt
antagonists Dkk1 and sFRP4 during adipogenesis of human
adipose tissue-derived mesenchymal stem cells. Cell Prolif
41:859–874
17. Seo KW, Lee SR, Bhandari DR, Roh KH, Park SB, So AY, Jung
JW, Seo MS, Kang SK, Lee YS, Kang KS (2009) OCT4A con-
tributes to the stemness and multi-potency of human umbilical
cord blood-derived multipotent stem cells (hUCB-MSCs). Bio-
chem Biophys Res Commun 384:120–125
18. Narita M, Krizhanovsky V, Nunez S, Chicas A, Hearn SA, Myers
MP, Lowe SW (2006) A novel role for high-mobility group a
proteins in cellular senescence and heterochromatin formation.
Cell 126:503–514
19. Jung JW, Cho SD, Ahn NS, Yang SR, Park JS, Jo EH, Hwang
JW, Jung JY, Kim SH, Kang KS, Lee YS (2005) Ras/MAP kinase
pathways are involved in Ras speciﬁc apoptosis induced by
sodium butyrate. Cancer Lett 225:199–206
20. Ferguson M, Henry PA, Currie RA (2003) Histone deacetylase
inhibition is associated with transcriptional repression of the
Hmga2 gene. Nucleic Acids Res 31:3123–3133
21. Jung JW, Lee S, Seo MS, Park SB, Kurtz A, Kang SK, Kang KS
(2010) Histone deacetylase controls adult stem cell aging by
balancing the expression of polycomb genes and jumonji domain
containing 3. Cell Mol Life Sci 67:1165–1176
22. Lee YS, Dutta A (2007) The tumor suppressor microRNA let-7
represses the HMGA2 oncogene. Genes Dev 21:1025–1030
23. Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B,
Dinulescu DM, Lengyel E, Peter ME (2007) Let-7 prevents early
cancer progression by suppressing expression of the embryonic
gene HMGA2. Cell Cycle 6:2585–2590
24. Tzatsos A, Bardeesy N (2008) Ink4a/Arf regulation by let-7b and
Hmga2: a genetic pathway governing stem cell aging. Cell Stem
Cell 3:469–470
25. Xu B, Huang Y (2009) Histone H2a mRNA interacts with Lin28
and contains a Lin28-dependent posttranscriptional regulatory
element. Nucleic Acids Res 37:4256–4263
26. Liu L, Luo GZ, Yang W, Zhao X, Zheng Q, Lv Z, Li W, Wu HJ,
Wang L, Wang XJ, Zhou Q (2010) Activation of the imprinted
Dlk1-Dio3 region correlates with pluripotency levels of mouse
stem cells. J Biol Chem 285:19483–19490
27. Li O, Vasudevan D, Davey CA, Droge P (2006) High-level
expression of DNA architectural factor HMGA2 and its associ-
ation with nucleosomes in human embryonic stem cells. Genesis
44:523–529
28. Eda A, Tamura Y, Yoshida M, Hohjoh H (2009) Systematic gene
regulation involving miRNAs during neuronal differentiation of
mouse P19 embryonic carcinoma cell. Biochem Biophys Res
Commun 388:648–653
29. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell
DA, Feig C, Lengyel E, Peter ME (2007) Let-7 expression
deﬁnes two differentiation stages of cancer. Proc Natl Acad Sci
USA 104:11400–11405
30. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T,
Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV
(2009) c-Myc suppression of miR-23a/b enhances mitochondrial
glutaminase expression and glutamine metabolism. Nature
458:762–765
31. Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale
T, Sobol RW, Dhir R (2006) Up-regulation of dicer, a component
of the MicroRNA machinery, in prostate adenocarcinoma. Am J
Pathol 169:1812–1820
32. Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol
RW, Dacic S (2007) Overexpression of dicer in precursor lesions
of lung adenocarcinoma. Cancer Res 67:2345–2350
33. Viswanathan SR, Daley GQ, Gregory RI (2008) Selective
blockade of microRNA processing by Lin28. Science 320:97–100
34. Kim W, Benhamed M, Servet C, Latrasse D, Zhang W, Delarue
M, Zhou DX (2009) Histone acetyltransferase GCN5 interferes
with the miRNA pathway in Arabidopsis. Cell Res 19:899–909
35. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-
Gomez J, Prosper F, Garcia-Foncillas J (2009) Epigenetic regu-
lation of microRNA expression in colorectal cancer. Int J Cancer
125:2737–2743
36. Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC (2006)
Rapid alteration of microRNA levels by histone deacetylase
inhibition. Cancer Res 66:1277–1281
37. Walton TJ, Li G, Seth R, McArdle SE, Bishop MC, Rees RC
(2008) DNA demethylation and histone deacetylation inhibition
co-operate to re-express estrogen receptor beta and induce
apoptosis in prostate cancer cell-lines. Prostate 68:210–222
38. You JS, Kang JK, Lee EK, Lee JC, Lee SH, Jeon YJ, Koh DH,
Ahn SH, Seo DW, Lee HY, Cho EJ, Han JW (2008) Histone
deacetylase inhibitor apicidin downregulates DNA methyltrans-
ferase 1 expression and induces repressive histone modiﬁcations
via recruitment of corepressor complex to promoter region in
human cervix cancer cells. Oncogene 27:1376–1386
39. Wang X, Xuan Z, Zhao X, Li Y, Zhang MQ (2009) High-reso-
lution human core-promoter prediction with CoreBoost_HM.
Genome Res 19:266–275
40. Liang R, Bates DJ, Wang E (2009) Epigenetic control of
MicroRNA expression and aging. Curr Genomics 10:184–193
336 S. Lee et al.